Pfizer Inc
PFE: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| << | LOCK|sS^# | LOCK|Fg!hhf |
Pfizer: Metsera Acquisition Puts Firm Back in Contention in Potential $200 Billion GLP-1 Market
Pfizer announced on Sept. 22 that it plans to acquire Metsera and its obesity drug candidates for $4.9 billion upfront and up to $2.4 billion in contingent payments based on pipeline progress.
